BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 18452141)

  • 1. A quantitative study of factors affecting in vivo bioluminescence imaging.
    Cui K; Xu X; Zhao H; Wong ST
    Luminescence; 2008; 23(5):292-5. PubMed ID: 18452141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo bioluminescence imaging.
    Sato A; Klaunberg B; Tolwani R
    Comp Med; 2004 Dec; 54(6):631-4. PubMed ID: 15679260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring of disease progression by bioluminescence imaging and magnetic resonance imaging in an animal model of hematologic malignancy.
    Inoue Y; Izawa K; Tojo A; Nomura Y; Sekine R; Oyaizu N; Ohtomo K
    Exp Hematol; 2007 Mar; 35(3):407-15. PubMed ID: 17309821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioluminescence: imaging modality for in vitro and in vivo gene expression.
    Sadikot RT; Blackwell TS
    Methods Mol Biol; 2008; 477():383-94. PubMed ID: 19082962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression level of luciferase within tumour cells can alter tumour growth upon in vivo bioluminescence imaging.
    Brutkiewicz S; Mendonca M; Stantz K; Comerford K; Bigsby R; Hutchins G; Goebl M; Harrington M
    Luminescence; 2007; 22(3):221-8. PubMed ID: 17286245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual luciferase labelling for non-invasive bioluminescence imaging of mesenchymal stromal cell chondrogenic differentiation in demineralized bone matrix scaffolds.
    Vilalta M; Jorgensen C; Dégano IR; Chernajovsky Y; Gould D; Noël D; Andrades JA; Becerra J; Rubio N; Blanco J
    Biomaterials; 2009 Oct; 30(28):4986-95. PubMed ID: 19539363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bioluminescence: the potential of a molecular non-invasive biooptical imaging technique and improvement of animal research].
    Hesselink JW; van Dam GM
    Tijdschr Diergeneeskd; 2007 Apr; 132(7):244-50. PubMed ID: 17458485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous delivery of D-luciferin by implanted micro-osmotic pumps enables true real-time bioluminescence imaging of luciferase activity in vivo.
    Gross S; Abraham U; Prior JL; Herzog ED; Piwnica-Worms D
    Mol Imaging; 2007; 6(2):121-30. PubMed ID: 17445506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Luciferin derivatives for enhanced in vitro and in vivo bioluminescence assays.
    Shinde R; Perkins J; Contag CH
    Biochemistry; 2006 Sep; 45(37):11103-12. PubMed ID: 16964971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A validated mouse model for orthotopic bladder cancer using transurethral tumour inoculation and bioluminescence imaging.
    Hadaschik BA; Black PC; Sea JC; Metwalli AR; Fazli L; Dinney CP; Gleave ME; So AI
    BJU Int; 2007 Dec; 100(6):1377-84. PubMed ID: 17850390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo study of the inflammatory modulating effects of low-level laser therapy on iNOS expression using bioluminescence imaging.
    Moriyama Y; Moriyama EH; Blackmore K; Akens MK; Lilge L
    Photochem Photobiol; 2005; 81(6):1351-5. PubMed ID: 16076245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative bioluminescence imaging of mouse tumor models.
    Tseng JC; Kung AL
    Cold Spring Harb Protoc; 2015 Jan; 2015(1):pdb.prot078261. PubMed ID: 25561617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioluminescent evaluation of the therapeutic effects of total body irradiation in a murine hematological malignancy model.
    Inoue Y; Izawa K; Kiryu S; Kobayashi S; Tojo A; Ohtomo K
    Exp Hematol; 2008 Dec; 36(12):1634-41. PubMed ID: 18951691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioluminescence imaging of bone metastasis in rodents.
    Snoeks TJ; van Beek E; Que I; Kaijzel EL; Löwik CW
    Methods Mol Biol; 2012; 816():507-15. PubMed ID: 22130947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic bioluminescence imaging for quantitative tumour burden assessment using IV or IP administration of D: -luciferin: effect on intensity, time kinetics and repeatability of photon emission.
    Keyaerts M; Verschueren J; Bos TJ; Tchouate-Gainkam LO; Peleman C; Breckpot K; Vanhove C; Caveliers V; Bossuyt A; Lahoutte T
    Eur J Nucl Med Mol Imaging; 2008 May; 35(5):999-1007. PubMed ID: 18180921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent achievements of bioluminescence imaging based on firefly luciferin-luciferase system.
    Li S; Ruan Z; Zhang H; Xu H
    Eur J Med Chem; 2021 Feb; 211():113111. PubMed ID: 33360804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive visualization of retinoblastoma growth and metastasis via bioluminescence imaging.
    Ji X; Cheng L; Wei F; Li H; Wang M; Tian Y; Chen X; Wang Y; Wolf F; Li C; Huang Q
    Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5544-51. PubMed ID: 19608529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive and quantitative monitoring of adult neuronal stem cell migration in mouse brain using bioluminescence imaging.
    Reumers V; Deroose CM; Krylyshkina O; Nuyts J; Geraerts M; Mortelmans L; Gijsbers R; Van den Haute C; Debyser Z; Baekelandt V
    Stem Cells; 2008 Sep; 26(9):2382-90. PubMed ID: 18599812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A potential role for imaging technology in anticancer efficacy evaluations.
    Hollingshead MG; Bonomi CA; Borgel SD; Carter JP; Shoemaker R; Melillo G; Sausville EA
    Eur J Cancer; 2004 Apr; 40(6):890-8. PubMed ID: 15120044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging neural stem cell fate in mouse model of glioma.
    Shah K
    Curr Protoc Stem Cell Biol; 2009 Mar; Chapter 5():Unit 5A.1. PubMed ID: 19306259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.